PHXIZEMON:
The final merger
Pfizer, AstraZeneca Are Ripe for Pharma Deal: Real M&A
Novartis and GSK trade assets as pharma industry reshapes
Novartis will sell its animal health business to Eli Lilly of the US for $5.4bn.
Valeant Pharmaceuticals and activist investor Bill Ackman succeed in their battle for control of Allergan, the maker of wrinkle treatment Botox
Astrazenca backed out! Too bad, I have this name copyrighted, the ulitmate name for the ultimate merger.